STOCK TITAN

Shareholder plans 30,000-share Rule 144 sale in Omeros (NASDAQ: OMER)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of OMER has filed a notice of proposed sales of common stock under Rule 144. The filing indicates an intention to sell 30,000 common shares through Morgan Stanley Smith Barney LLC on or about 01/12/2026 on the NASDAQ, with an indicated aggregate market value of $381,600.00. The shares relate to prior open market purchases of 10,000 shares on 05/15/2022 and 20,000 shares on 11/14/2023, both paid in cash. The document notes that the person signing represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many OMER shares are proposed to be sold under this Rule 144 notice?

The notice covers a proposed sale of 30,000 shares of common stock of OMER.

What is the aggregate market value of the OMER shares in this planned Rule 144 sale?

The filing shows an aggregate market value of $381,600.00 for the 30,000 common shares to be sold.

Through which broker will the OMER shares be sold and on which exchange?

The proposed sales are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange.

When were the OMER shares being sold under this notice originally acquired?

The filing lists 10,000 common shares acquired on 05/15/2022 and 20,000 common shares acquired on 11/14/2023, both as open market purchases paid in cash.

What is the approximate planned sale date for the OMER shares in this Rule 144 filing?

The approximate date of sale disclosed is 01/12/2026.

How many OMER shares are outstanding according to this Rule 144 notice?

The securities information section reports 70,900,459 common shares outstanding for the issuer.

What representation does the selling shareholder make about OMER in this notice?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Omeros

NASDAQ:OMER

OMER Rankings

OMER Latest News

OMER Latest SEC Filings

OMER Stock Data

856.48M
68.95M
3.79%
42.7%
19.31%
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE